Company: SUPN
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001104659-25-042531
Chunk: 61

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 61
---
. Barlow received a $50,000 annual Board retainer, $20,000 for her service as Chairman of the Science Committee, and $6,000 for her service as a member of the Governance and Nominating Committee. (6) Ms. Sensenig received a $50,000 annual Board retainer and $12,500 for her service as a member of the Audit Committee. (7) Mr. Siebert received a $25,000 annual Board retainer, $6,250 for his service as a member of the Audit Committee, $10,000 for his service as a member of the Compensation Committee, and $5,000 for his service as a member of the Science Committee. Payments to Mr. Siebert were pro-rated based on his service on the Board and its committees through June 14, 2024. Includes the incremental fair value of stock awards as a result of the acceleration of vesting of previously awarded restricted stock units upon Mr. Siebert’s retirement from the Board. Equity Awards In addition to the cash retainers set forth above, for 2024, the Compensation Committee recommended and the Board of Directors approved the following equity awards to our then serving non-employee directors on February 22, 2024. Stock Option Awards On February 22, 2024, each then serving non-employee director received approximately 50% of the grantee’s annual equity award as non-statutory stock options to purchase shares of the Company’s Common Stock. The options granted to non-employee directors have an exercise price of $27.94, which is equal to the closing price of the Company’s Common Stock on the date of the grant, and are subject to a ten-year term and vest at the end of the one-year period following the date of grant. Restricted Stock Unit Awards On February 22, 2024, each then serving non-employee director received approximately 50% of the grantee’s annual equity award in restricted stock units equal to $150,000 of the Company’s Common Stock, which resulted in a grant date fair value of $150,009. These restricted stock unit awards vest at the end of the one-year period following the date of grant and are subject to forfeiture if the grantee ceases to be a member of the Board of Directors for any reason prior to the award’s vesting date. 46 REPORT OF THE AUDIT COMMITTEE The Audit Committee has reviewed and discussed our audited consolidated financial statements with management. The Audit Committee has discussed